The Fund does not undertake investment in idea /seed stage. Companies which are earning revenue from core their activities are only entertained (product / high-end services / solutions etc.). The Fund supports companies for enhancing their existing offering to customers and also expand / diversify using core competency which will enhance shareholder value.
KITVEN Fund – 3 (Biotech)
The Fund does not undertake investment in idea stage. The Fund undertakes investment in Biotechnology companies to further enhance/ develop the core competency in niche, high-end IP / products. The Fund will look for investment favourably in companies without insisting for revenue from core IP/ product.